MedPath

A randomized controlled trial for Xiao-Qing-Long Decoction in the treatment of refractory asthma

Phase 1
Conditions
refractory asthma
Registration Number
ITMCTR1900002783
Lead Sponsor
Hospital of Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Agde 18-65 years men or women, diagnosis of bronchial asthma for at least 1 year;
2. Patients conform to the diagnostic criteria of Western medicine refractory asthma;
3. Patients conform to the diagnostic standard of Chinese medicine asthma External Cold and Internal Fluid Syndrome;
4. Patients own good ability to read, understand and write research-related materials and comply with all trail requirements on a voluntary basis;
5. Patients voluntarily participate in research and sign informed consent form.

Exclusion Criteria

1. Patients have a respiratory infection within 4 weeks;
2. Patients with chronic lung diseases require intervention or treatment such as chronic obstructive pulmonary disease, interstitial lung disease, active tuberculosis, bronchial dilation ;
3. Patients with serious primary diseases such as severe mental and psychological disorders, heart and brain vessels diseases, liver and kidney diseases, endocrine diseases, hematopoietic system diseases and malignant tumors ;
4. Patients take antibiotics within 3 months and eat yogurt or probiotics within 1 month;
?
5. Patients are unwilling or unable to change the current treatment plan;
6. Patients are known to be allergic to trail drugs or a certain Chinese medicine of this study;
7. Women are breastfeeding, pregnant or preparing for pregnancy;
8. Patients have more than 15 packs per year of smoking history ;
9. Patients have participated in other clinical studies in the past six months.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Asthma Control Test(ACT) score;
Secondary Outcome Measures
NameTimeMethod
Pulmonary function(FEV1, FEV1/FVC, daytime and night peak expiratory flow(PEF));Average daily use of drugs that relieve asthma;Curative effect of TCM syndrome;Asthma Quality of Life Questionnaire(AQLQ);Changes in the composition of intestinal flora in the faeces of subjects;
© Copyright 2025. All Rights Reserved by MedPath